These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 8687011)

  • 41. Evidence that specific mtDNA point mutations may not accumulate in skeletal muscle during normal human aging.
    Pallotti F; Chen X; Bonilla E; Schon EA
    Am J Hum Genet; 1996 Sep; 59(3):591-602. PubMed ID: 8751860
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mitochondrial DNA maintenance: an appraisal.
    Akhmedov AT; Marín-García J
    Mol Cell Biochem; 2015 Nov; 409(1-2):283-305. PubMed ID: 26286847
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Apoptosis in mitochondrial myopathies is linked to mitochondrial proliferation.
    Auré K; Fayet G; Leroy JP; Lacène E; Romero NB; Lombès A
    Brain; 2006 May; 129(Pt 5):1249-59. PubMed ID: 16537564
    [TBL] [Abstract][Full Text] [Related]  

  • 44. An update on the mitochondrial-DNA mutation hypothesis of cell aging.
    Miquel J
    Mutat Res; 1992 Sep; 275(3-6):209-16. PubMed ID: 1383762
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mouse models for mitochondrial disease.
    Wallace DC
    Am J Med Genet; 2001; 106(1):71-93. PubMed ID: 11579427
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Point mutations of mitochondrial genome in Parkinson's disease.
    Ikebe S; Tanaka M; Ozawa T
    Brain Res Mol Brain Res; 1995 Feb; 28(2):281-95. PubMed ID: 7723627
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Mitochondrial DNA mutations and three major forms of mitochondrial myopathies: CPEO, MELAS and MERRF].
    Goto Y
    Nihon Rinsho; 1997 Dec; 55(12):3259-64. PubMed ID: 9436447
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Oxidative stress, mitochondrial DNA mutation, and apoptosis in aging.
    Lee HC; Wei YH
    Exp Biol Med (Maywood); 2007 May; 232(5):592-606. PubMed ID: 17463155
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Accumulation of mitochondrial DNA deletions within dopaminergic neurons triggers neuroprotective mechanisms.
    Perier C; Bender A; García-Arumí E; Melià MJ; Bové J; Laub C; Klopstock T; Elstner M; Mounsey RB; Teismann P; Prolla T; Andreu AL; Vila M
    Brain; 2013 Aug; 136(Pt 8):2369-78. PubMed ID: 23884809
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A new point mutation at nucleotide pair 3291 of the mitochondrial tRNA(Leu(UUR)) gene in a patient with mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS).
    Goto Y; Tsugane K; Tanabe Y; Nonaka I; Horai S
    Biochem Biophys Res Commun; 1994 Aug; 202(3):1624-30. PubMed ID: 7520241
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Peroxide production and apoptosis in cultured cells carrying mtDNA mutation causing encephalomyopathy.
    Zhang J; Yoneda M; Naruse K; Borgeld HJ; Gong JS; Obata S; Tanaka M; Yagi K
    Biochem Mol Biol Int; 1998 Sep; 46(1):71-9. PubMed ID: 9784841
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The pathogenic A3243G mutation in human mitochondrial tRNALeu(UUR) decreases the efficiency of aminoacylation.
    Park H; Davidson E; King MP
    Biochemistry; 2003 Feb; 42(4):958-64. PubMed ID: 12549915
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A novel point mutation in the mitochondrial tRNA(Ser(UCN)) gene detected in a family with MERRF/MELAS overlap syndrome.
    Nakamura M; Nakano S; Goto Y; Ozawa M; Nagahama Y; Fukuyama H; Akiguchi I; Kaji R; Kimura J
    Biochem Biophys Res Commun; 1995 Sep; 214(1):86-93. PubMed ID: 7669057
    [TBL] [Abstract][Full Text] [Related]  

  • 54. MELAS- and Kearns-Sayre-type co-mutation [corrected] with myopathy and autoimmune polyendocrinopathy.
    Ohno K; Yamamoto M; Engel AG; Harper CM; Roberts LR; Tan GH; Fatourechi V
    Ann Neurol; 1996 Jun; 39(6):761-6. PubMed ID: 8651648
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Biocomplexity and Fractality in the Search of Biomarkers of Aging and Pathology: Mitochondrial DNA Profiling of Parkinson's Disease.
    Zaia A; Maponi P; Zannotti M; Casoli T
    Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32143500
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Melas with point mutations involving tRNALeu (A3243G) and tRNAGlu(A14693g).
    Tzen CY; Thajeb P; Wu TY; Chen SC
    Muscle Nerve; 2003 Nov; 28(5):575-81. PubMed ID: 14571459
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mitochondrial genome function and maternal inheritance.
    Allen JF; de Paula WB
    Biochem Soc Trans; 2013 Oct; 41(5):1298-304. PubMed ID: 24059523
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Metabolic interventions against complex I deficiency in MELAS syndrome.
    Majamaa K; Rusanen H; Remes A; Hassinen IE
    Mol Cell Biochem; 1997 Sep; 174(1-2):291-6. PubMed ID: 9309702
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes (MELAS) with the A3243G mutation of the tRNALeu(UUR) gene of mtDNA in native American haplogroup B2].
    Delgado-Sánchez R; Zárate-Moysen A; Monsalvo-Reyes A; Herrero MD; Ruiz-Pesini E; López-Pérez M; Montoya J; Montiel-Sosa JF
    Rev Neurol; 2007 Jan 1-15; 44(1):18-22. PubMed ID: 17199225
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Functional mitochondrial heterogeneity in heteroplasmic cells carrying the mitochondrial DNA mutation associated with the MELAS syndrome (mitochondrial encephalopathy, lactic acidosis, and strokelike episodes).
    Bakker A; Barthélémy C; Frachon P; Chateau D; Sternberg D; Mazat JP; Lombès A
    Pediatr Res; 2000 Aug; 48(2):143-50. PubMed ID: 10926287
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.